Updated Date: Mon, 21 Apr 2025 00:00:00 EDT
A new study uses AI to modify drug doses for personalized cancer treatment.
MHRA authorises drug for adults with rare heart muscle damage
It is hoped that the MAGIC-I study will support earlier diagnosis and personalised treatment
Piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less […]
Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable […]
The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK
Updated Date: Wed, 16 Apr 2025 00:00:00 EDT
Researchers have made a breakthrough discovery that could potentially revolutionize treatments for antibiotic-resistant infections, cancer and other challenging […]
